SEC Filing Summary: Healthcare Acquisition Corp. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Healthcare Acquisition Corp. on November 30, 2005, reporting events occurring on November 28, 2005. The registrant is a Delaware corporation headquartered in Des Moines, Iowa. Note: The input metadata references "Altimmune, Inc." and a 2005 date, but the filing text explicitly identifies the registrant as Healthcare Acquisition Corp.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and trading plan disclosures rather than financial performance.
Material Changes
There are no material changes to financial operations or business strategy reported in this document. The sole material event is the adoption of Rule 10b5-1(c) trading plans by key executives.
Management Commentary and Unusual Items
On November 28, 2005, the following officers entered into written individual purchase plans with Citigroup Global Markets ("CGM") to comply with Rule 10b5-1(c):
- John Pappajohn (Chairman of the Board and Secretary)
- Derace L. Schaffer, MD (Chief Executive Officer)
- Matthew P. Kinley (President)
These plans authorize CGM to purchase specified amounts of the Company's publicly traded warrants (exercisable for common stock) commencing November 29, 2005, subject to specified price ranges and terms. This action establishes an affirmative defense against insider trading liability for these transactions.
Investor Verification Checklist
- Verify the specific price ranges and volume limits set within the Rule 10b5-1(c) plans for the warrants.
- Confirm the total number of warrants held by the executives prior to the execution of these plans.
- Monitor future filings to track the actual execution of warrant purchases under these plans.
- Clarify the relationship between the metadata reference to "Altimmune, Inc." and the registrant "Healthcare Acquisition Corp."